Firm reiterates commitment to “No Woman Should Die of Cervical Cancer” policy
QIAGEN in partnership with Turner Wright Biosciences and The Specialist Laboratories on Saturday reiterated commitment to its policy of “No Woman Should die of Cervical Cancer”.
Dr Tunde Lawal, Managing Director, Turner Wright Biosciences Limited, disclosed this in Lagos during the commemoration of the World Cancer Day.
Lawal said that QIAGEN, a biotech company based in Germany, with its policy of leaving no one behind was committed to eradicating cervical cancer.
He said that the company developed the first HPV DNA test , which remained the only test proven to reduce mortality from cervical cancer and also a simplified more cost-effective option for Africa.
“Turner Wright Biosciences is a premium supplier of products from leading brands and also the commercial partner of QIAGEN in Nigeria.
“As an advocate of ‘No Woman Should Die of Cervical Cancer” we have been bridging the gap in cancer diagnosis by making sure that QIAGEN solutions for cervical cancer screening are readily available for laboratories and institutions.
“The Specialist Laboratories is known for its efficient and qualitative specialised services with a track record of excellent service delivery,” he said.
Lawal said that World Cancer Day was a reminder to everyone about a disease that was 100 per cent preventable and the solution to do this was their hands.
The Managing Director said that no woman needed to die prematurely from a virus that had a vaccine and could be treated provided it was diagnosed early enough.
He said that it was important to remind the public that cervical cancer had been proven to be preventable and treated in other parts of the world, Nigeria should not be an exception.
He said that with the political will, advocacy and support, the country could bridge the gap in cervical cancer mortality.
He said the mission was to ensure that in the next decade, no woman in Nigeria should die of cervical cancer.
Earlier, the Commandant, Police College, C P Ayoola Ajala, had said that cervical cancer screening helped patients to know their status.
Ajala, who was represented by SP Laura Jogbenu, Headmaster of the Police College, said that the screening was free.
He said that knowing one’s status helped in tackling the disease and advised all women to present and make themselves available for the test.
The screening exercise took place at the Police College Hospital and not less than 80 women were screened.
The participants were enlightened about the causes, management and treatment before screening.
